Henstridge CM - Search Results

1

Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.

Henstridge CM, Balenga NA, Kargl J, Andradas C, Brown AJ, Irving A, Sanchez C, Waldhoer M. Henstridge CM, et al. Mol Endocrinol. 2011 Nov;25(11):1835-48. doi: 10.1210/me.2011-1197. Epub 2011 Sep 29. Mol Endocrinol. 2011. PMID: 21964594 Free PMC article. Review.

2

The transparent minds: methods of creation of 3D digital models from patient specific data.

Pokojna H, Erolin C, Henstridge C. Pokojna H, et al. J Vis Commun Med. 2022 Apr;45(2):17-31. doi: 10.1080/17453054.2021.2008230. Epub 2022 Jan 12. J Vis Commun Med. 2022. PMID: 35019795

3

An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor.

McDonald NA, Henstridge CM, Connolly CN, Irving AJ. McDonald NA, et al. Among authors: henstridge cm. Mol Pharmacol. 2007 Apr;71(4):976-84. doi: 10.1124/mol.106.029348. Epub 2006 Dec 20. Mol Pharmacol. 2007. PMID: 17182888

4

Generation and functional characterization of fluorescent, N-terminally tagged CB1 receptor chimeras for live-cell imaging.

McDonald NA, Henstridge CM, Connolly CN, Irving AJ. McDonald NA, et al. Among authors: henstridge cm. Mol Cell Neurosci. 2007 Jun;35(2):237-48. doi: 10.1016/j.mcn.2007.02.016. Epub 2007 Mar 3. Mol Cell Neurosci. 2007. PMID: 17467290

5

The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.

Henstridge CM, Balenga NA, Ford LA, Ross RA, Waldhoer M, Irving AJ. Henstridge CM, et al. FASEB J. 2009 Jan;23(1):183-93. doi: 10.1096/fj.08-108670. Epub 2008 Aug 29. FASEB J. 2009. PMID: 18757503

6

Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and 'cannabinoid-like' receptors in small arteries.

Daly CJ, Ross RA, Whyte J, Henstridge CM, Irving AJ, McGrath JC. Daly CJ, et al. Among authors: henstridge cm. Br J Pharmacol. 2010 Feb;159(4):787-96. doi: 10.1111/j.1476-5381.2009.00608.x. Epub 2010 Feb 5. Br J Pharmacol. 2010. PMID: 20136833 Free PMC article.

7

GPR55 ligands promote receptor coupling to multiple signalling pathways.

Henstridge CM, Balenga NA, Schröder R, Kargl JK, Platzer W, Martini L, Arthur S, Penman J, Whistler JL, Kostenis E, Waldhoer M, Irving AJ. Henstridge CM, et al. Br J Pharmacol. 2010 Jun;160(3):604-14. doi: 10.1111/j.1476-5381.2009.00625.x. Epub 2010 Feb 5. Br J Pharmacol. 2010. PMID: 20136841 Free PMC article.

8

Pharmacology, signaling and physiological relevance of the G protein-coupled receptor 55.

Balenga NA, Henstridge CM, Kargl J, Waldhoer M. Balenga NA, et al. Among authors: henstridge cm. Adv Pharmacol. 2011;62:251-77. doi: 10.1016/B978-0-12-385952-5.00004-X. Adv Pharmacol. 2011. PMID: 21907912 Review.

9

Off-target cannabinoid effects mediated by GPR55.

Henstridge CM. Henstridge CM. Pharmacology. 2012;89(3-4):179-87. doi: 10.1159/000336872. Epub 2012 Mar 16. Pharmacology. 2012. PMID: 22433274 Review.

10

GPR55: Metabolic Help or Hindrance?

Henstridge CM, Brown AJ, Waldhoer M. Henstridge CM, et al. Trends Endocrinol Metab. 2016 Sep;27(9):606-608. doi: 10.1016/j.tem.2016.04.012. Epub 2016 May 21. Trends Endocrinol Metab. 2016. PMID: 27215467 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters